Australia markets closed

Soleno Therapeutics, Inc. (SLNO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.6700+0.0400 (+2.45%)
At close: 04:00PM EDT
1.7300 +0.06 (+3.59%)
After hours: 07:30PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
0
0
0
0
0
Operating expenses
Research development
16,386
21,453
23,191
16,267
7,178
Selling general and administrative
10,473
10,806
8,758
6,930
6,556
Total operating expenses
26,859
32,259
31,949
23,197
13,734
Operating income or loss
-26,859
-32,259
-31,949
-23,197
-13,734
Interest expense
-
-
-
-
62
Total other income/expenses net
3,300
1,239
7,297
-7,731
1,955
Income before tax
-23,417
-30,910
-24,639
-30,774
-11,841
Income tax expense
-
-
-
-
0
Income from continuing operations
-23,417
-30,910
-24,639
-30,774
-11,841
Net income
-23,417
-30,910
-24,639
-30,774
-13,335
Net income available to common shareholders
-23,417
-30,910
-24,639
-30,774
-13,335
Basic EPS
-
-5.85
-5.85
-13.50
-9.60
Diluted EPS
-
-5.85
-5.85
-13.50
-9.60
Basic average shares
-
5,318
4,175
2,276
1,398
Diluted average shares
-
5,318
4,175
2,276
1,398
EBITDA
-
-30,296
-29,995
-21,239
-11,771